Articles from Mirion Technologies, Inc.

Mirion (“we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2024.

Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $7.65 per share. Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners. Mirion will not sell any securities in the public offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders, but Mirion will bear the costs associated with the public offering, other than underwriting discounts and commissions and certain other expenses. The offering is expected to close on May 16, 2023, subject to customary closing conditions.

Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the commencement of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders. Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners. Mirion will not sell any securities in the proposed offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders, but Mirion will bear the costs associated with the proposed offering, other than underwriting discounts and commissions and certain other expenses. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Mirion ("we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2023.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs’ Industrials & Materials Conference in New York, NY. The presentation will begin at 9:20 AM ET on Tuesday, May 9, 2023.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the first quarter of 2023 on Wednesday, May 3, 2023. Following the news release, the Company will host a conference call the same day at 12:00 pm ET to discuss the results.

Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an underwritten public offering of 9,786,153 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $8.75 per share. Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners. Mirion will not sell any securities in the public offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders but Mirion will bear the costs associated with the public offering, other than underwriting discounts and commissions and certain other expenses. The offering is expected to close on March 7, 2023, subject to customary closing conditions.

Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the commencement of an underwritten public offering of 9,786,153 shares of Mirion’s Class A common stock by certain selling stockholders. Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners. Mirion will not sell any securities in the proposed offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders but Mirion will bear the costs associated with the proposed offering, other than underwriting discounts and commissions and certain other expenses. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it has agreed to sell $150 million of shares of Class A common stock to certain funds and accounts advised by T. Rowe Price Investment Management, Inc. (“T. Rowe Price”), a global investment management organization.

Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the fourth quarter and fiscal year ended December 31, 2022.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2023 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Tuesday, February 21, 2023.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the fourth quarter and fiscal year 2022 on Tuesday, February 14, 2023. Following the news release, the Company will host a conference call the same day at 10:00 am ET to discuss the results.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the CJS Securities 23rd Annual New Ideas for the New Year Conference. The presentation will begin at 3:45 PM ET on Wednesday, January 11, 2023.

Mirion Technologies, Inc. (NYSEMIR) announced today that it has entered into a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. (“Biodex”) to Salona Global Medical Device Corporation for $5 million in cash at closing and up to an additional $3 million in deferred cash payments. The deferred cash payments are contingent on the performance of the assets during the 12-month period following closing. The assets generated approximately $18 million in revenue with estimated gross margins of 30% during the most recent trailing twelve-month period.

Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2022.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the 2022 Baird Industrial Conference in Chicago, IL. The presentation will begin at 11:50 AM ET on Thursday, November 10, 2022.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the third quarter of 2022 on Tuesday, November 1, 2022 after the market closes. Following the news release, the Company will host a conference call the same day at 4:30 pm ET to discuss the results.

Mirion Technologies, Inc. (“Mirion,” “we” or the “Company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion’s CEO, Tom Logan, who had been acting as President of the business segment.

Mirion Technologies, Inc. (“Mirion,” “we” or the “Company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Dr. Sheila Rege, M.D. has been appointed to the Board of Directors, replacing Mr. Christopher Warren, who is stepping down.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”), a leading provider of comprehensive systems that detect and monitor radiation in medical, industrial and defense end markets, today announced the acquisition of the Critical Infrastructure (CI) business of Collins Aerospace (through ARINC Incorporated, a subsidiary of Collins Aerospace) is now complete, and the CI business will integrate under the Mirion brand as Secure Integrated Solutions (SIS).

Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for its fiscal quarter ended June 30, 2022.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Jefferies Industrials Conference in New York, NY. The presentation will begin at 1:00 PM ET on Wednesday, August 10, 2022.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the second quarter of 2022 on Friday, July 29, 2022. Following the news release, the Company will host a conference call the same day at 10:00 am ET to discuss the results.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”), today announced the rebranding of its Medical segment as the Mirion Medical group, comprised of the organization’s healthcare-focused Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units. The establishment of the Mirion Medical group reinforces the Mirion commitment to leveraging its expertise in ionizing radiation for healthcare applications.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at CJS Securities’ 22nd Annual “New Ideas” Summer Conference in Greenwich, CT on Tuesday, July 12, 2022.

Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for its fiscal quarter ended March 31, 2022.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs’ Industrials and Materials Conference in New York, NY. The presentation will begin at 11:20 AM ET on Tuesday, May 10, 2022.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Well Fargo’s 2022 Industrials Conference in New York, NY. The presentation will begin at 12:00 PM ET on Thursday, May 5, 2022.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the first quarter of 2022 on Wednesday, May 4, 2022. Following the news release, the Company will host a conference call the same day at 11:00 am ET to discuss the results.

Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for its fiscal quarter and fiscal year ended December 31, 2021.

Mirion Technologies, Inc. (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2022 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Thursday, February 24, 2022.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021 on Wednesday, February 23, 2022. Following the news release, the Company will host a conference call the same day at 10:00 am ET to discuss the results.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the release of the Hyperion™ Compact Digital High Radiation Tolerant Camera, now offered in color and monochrome versions. With the Hyperion Compact camera’s digital performance and radiation tolerance, cost of ownership can be reduced while performance is enhanced—all within a compact package.

Mirion Technologies, Inc. (NYSEMIR) (“Mirion”) (“Company”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it had completed the acquisition of Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.

Mirion Technologies, Inc. (“Mirion”) (NYSEMIR), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the quarter ended September 30, 2021 for Mirion Technologies (TopCo), Ltd (“Legacy Mirion”). Legacy Mirion was the parent company for the Mirion business before the business combination with GS Acquisition Holdings Corp II (“GSAH”) which closed on October 20, 2021.

Mirion Technologies, Inc. (NYSEMIR)(“Mirion”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the signing of a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.

Mirion Technologies, Inc. (NYSEMIR), announced today that it will release financial results for Mirion Technologies (TopCo), Ltd for the fiscal quarter ended September 30, 2021, on Friday, November 12, 2021 before the market opens. The company will host a conference call the same day at 8:00 am ET to present the results.

Mirion Technologies, Inc. (“Mirion”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the acquisition of CHP Dosimetry, a U.S.-based distributor of dosimetry services. The acquisition closed on November 1, 2021.

Mirion Technologies, Inc. (“Mirion”) (NYSEMIR), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, announced that its Class A common stock and warrants will begin trading on the New York Stock Exchange today under the symbols “MIR” and “MIRW,” respectively. Management will participate in a closing bell ceremony at the New York Stock Exchange today, October 21, 2021, in celebration of the public listing.

Mirion Technologies, Inc. (“Mirion” or “the Company”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the receipt of all regulatory approvals in connection with the proposed business combination with GS Acquisition Holdings Corp II (NYSEGSAH) (“GSAH”).

Mirion Technologies, Inc. (“Mirion”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the acquisition of the Dosimetry Badge brand—a small, US-based distributor of personal dosimeter badges.

Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, today announced the nominees for election to the Board of Directors following its proposed business combination with GS Acquisition Holdings Corp II (“GSAH”). Each nominee is a leader within his or her respective field and brings a wealth of experience, knowledge and expertise. The nominees are Thomas D. Logan, Lawrence D. Kingsley, Jyothsna (Jo) Natauri, Christopher Warren, Steven Etzel, Kenneth C. Bockhorst Robert A. Cascella, John Wei-Ching Kuo and Jody A. Markopoulos.

Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, today announced two upcoming job fairs to support the expansion of its Oak Ridge operations.

Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, today announced the release of its new Apex-Guard software, an exciting addition to the Mirion Apex-Gamma™ Lab Productivity Suite.

Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research markets, announced today the release of the Orion™ Real-Time Location System (“Orion RTLS”). The Orion RTLS System supports critical work path efficiency, worker safety, asset location and dose management activities by unifying radiological and location data using real-time location compatible devices and asset tags. The Orion RTLS System is a key product in Mirion’s growing suite of data-enabled radiation measurement and analysis solutions and represents the 4th generation of Mirion’s wireless technology for remote monitoring of radiation measurement data, seamlessly bringing exact location information into the remote monitoring ecosystem.

Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, research and defense end markets, today announced its fiscal year 2021 results.

Mirion Technologies, Inc. (Mirion), a global provider of mission-critical radiation detection and measurement solutions that recently announced a proposed business combination with GS Acquisition Holdings Corp II (“GSAH”) (NYSE: GSAH, GSAH.U, GSAH WS), a special purpose acquisition company sponsored by an affiliate of The Goldman Sachs Group, Inc., today announced it has delivered the first shipment of 880 AccuRad PRDs as an awardee in a $121 million dollar IDIQ contract with the Department of Homeland Security’s (DHS) Countering Weapons of Mass Destruction (CWMD). Mirion expects to deliver a total of 4,001 AccuRad PRDs to support the Securing the Cities initiative in the first year.

Mirion Technologies, Inc. (“Mirion”), a Charterhouse Capital Partners LLP (“Charterhouse”) portfolio company, and a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, announced today that it will present at the Raymond James Diversified Industrials Conference. Members of management will present on Wednesday, August 25, at 11:00 am ET. A webcast of the event will be available at the link HERE.

Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, today announced the launch of Mirion Lab-Pulse™ Services (“LabPulse Services”), a comprehensive value-based Internet of Things offering for High Purity Germanium systems to improve count room and laboratory uptime.